Developing a community HCV service: project ITTREAT (integrated community-based test – stage – TREAT) service for people who inject drugs

Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment

(2016) Heather Lewis et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

(2016) Natasha K. Martin et al.   JOURNAL OF HEPATOLOGY

Guided, internet-based, rumination-focused cognitive behavioural therapy (i-RFCBT) versus a no-intervention control to prevent depression in high-ruminating young adults, along with an adjunct assessment of the feasibility of unguided i-RFCBT, in the REducing Stress and Preventing Depression trial (RESPOND): study protocol for a phase III randomised controlled trial

(2016) Lorna Cook et al.   Trials

Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatment

(2016) Nik Howes et al.   Open Forum Infectious Diseases

Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study

(2015) Jason Grebely et al.   ADDICTION

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

(2015) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Strategies to manage hepatitis C virus (HCV) disease burden

(2014) H. Wedemeyer et al.   JOURNAL OF VIRAL HEPATITIS

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiviral Resistance and Correlates of Virologic Failure in the first Cohort of HIV-Infected Children Gaining Access to Structured Antiretroviral Therapy in Lima, Peru: A Cross-Sectional Analysis

(2013) Barbara A Rath et al.   BMC INFECTIOUS DISEASES

Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit All

(2013) Philip Bruggmann et al.   CLINICAL INFECTIOUS DISEASES

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

(2013) Natasha K. Martin et al.   HEPATOLOGY

Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers

(2012) Muchandidemba Marufu et al.   JOURNAL OF MEDICAL VIROLOGY

Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis

(2011) Ross J. Harris et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

Prospective validation of the short form liver disease quality of life instrument

(2008) F. KANWAL et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C

(2008) K. JACK et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use

(2008) M. WILKINSON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy and Safety of Peginterferon Alfa-2a/Ribavirin in Methadone Maintenance Patients: Randomized Comparison of Direct Observed Therapy and Self-Administration

(2008) Herbert L. Bonkovsky et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY